Literature DB >> 10391857

Outcomes of Bordetella infections in vaccinated children: effects of bacterial number in the nasopharynx and patient age.

Q He1, H Arvilommi, M K Viljanen, J Mertsola.   

Abstract

Five outbreaks of infection (three pertussis, one parapertussis, and one mixed) in schools were studied prospectively. Nasopharyngeal swabs were obtained from a total of 697 children for culture of Bordetella organisms. Of 50 vaccinated children with culture-confirmed Bordetella infections (29 with pertussis and 21 parapertussis), 40 were symptomatic and 10 remained symptom-free. Smaller numbers of colonies were recovered from the nasopharyngeal swabs of the asymptomatic children than from those of the symptomatic children. Older children had longer durations of illness than younger ones. Our results indicate that during outbreaks children who do not develop disease may have small amounts of Bordetella organisms in their nasopharynges and/or better immune defenses against the disease.

Entities:  

Mesh:

Year:  1999        PMID: 10391857      PMCID: PMC95722          DOI: 10.1128/CDLI.6.4.534-536.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  15 in total

1.  EPIDEMIOLOGY OF A SMALL PERTUSSIS OUTBREAK IN KENT COUNTY, MICHIGAN.

Authors:  H J LAMBERT
Journal:  Public Health Rep       Date:  1965-04       Impact factor: 2.792

2.  Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study.

Authors:  D Jenkinson
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-27

Review 3.  Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum.

Authors:  J B Robbins; R Schneerson; S C Szu
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

4.  Reported vaccine-preventable diseases--United States, 1993, and the childhood immunization initiative.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1994-02-04       Impact factor: 17.586

5.  A search for Bordetella pertussis infection in university students.

Authors:  C M Mink; J D Cherry; P Christenson; K Lewis; E Pineda; D Shlian; J A Dawson; D A Blumberg
Journal:  Clin Infect Dis       Date:  1992-02       Impact factor: 9.079

6.  Impact of polymerase chain reaction on clinical pertussis research: Finnish and Swiss experiences.

Authors:  Q He; G Schmidt-Schläpfer; M Just; H C Matter; S Nikkari; M K Viljanen; J Mertsola
Journal:  J Infect Dis       Date:  1996-12       Impact factor: 5.226

7.  Outcomes of Bordetella pertussis infection in different age groups of an immunized population.

Authors:  Q He; M K Viljanen; S Nikkari; R Lyytikäinen; J Mertsola
Journal:  J Infect Dis       Date:  1994-10       Impact factor: 5.226

8.  Placebo-controlled trial of two acellular pertussis vaccines in Sweden--protective efficacy and adverse events. Ad Hoc Group for the Study of Pertussis Vaccines.

Authors: 
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

9.  Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren.

Authors:  Q He; M K Viljanen; R M Olander; H Bogaerts; D De Grave; O Ruuskanen; J Mertsola
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

10.  Bordetella pertussis infection: a cause of persistent cough in adults.

Authors:  P W Robertson; H Goldberg; B H Jarvie; D D Smith; L R Whybin
Journal:  Med J Aust       Date:  1987-05-18       Impact factor: 7.738

View more
  1 in total

1.  Use of Bordetella pertussis BP3385 to establish a cutoff value for an IS481-targeted real-time PCR assay.

Authors:  J L Guthrie; C Seah; S Brown; P Tang; F Jamieson; S J Drews
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.